Table 3

Effect of mental disorders use on any lifetime MHC use and type of MHC use, stratified by gender

 Any mental healthcare useAny lifetime general practitioner versus psychiatrist/other mental health use
WomenMenWomenMen
OR (95% CI)OR (95% CI)OR (95% CI)OR (95% CI)
(n=10 199)(n=7313)p for intxn(n=3660)(n=1648)p for intxn
Any lifetime mood disorder*6.18 (5.45 to 7.00)7.07 (5.93 to 8.44)0.20.71 (0.59 to 0.84)0.67 (0.52 to 0.87)0.8
Any lifetime anxiety disorder†3.15 (2.71 to 3.66)4.44 (3.58 to 5.49)0.0080.88 (0.72 to 1.06)0.65 (0.49 to 0.86)0.08
Any alcohol use disorder2.33 (1.63 to 3.34)3.14 (2.54 to 3.89)0.150.84 (0.52 to 1.35)0.67 (0.46 to 0.96)0.5
Mental health severity
 None1.001.001.001.00
 Mild3.84 (3.08 to 4.79)5.12 (3.50 to 7.50)0.191.04 (0.80 to 1.35)0.88 (0.53 to 1.47)0.6
 Moderate4.99 (4.13 to 6.04)6.21 (4.79 to 8.06)0.20.81 (0.63 to 1.04)0.77 (0.53 to 1.14)0.8
 Severe8.95 (6.96 to 11.49)14.70 (10.16 to 21.27)0.030.57 (0.43 to 0.76)0.36 (0.22 to 0.58)0.1
  • Data presented are from the Part II samples of the ESeMED survey and separate surveys from Northern Ireland, Bulgaria, Romania and Portugal. All ORs were adjusted by age, income level, employment status, education, marital status and country-level indicators (index of MHC provision, private household out-of-pocket expenditure, and gender gap index). For each disorder, the interaction by gender was tested by including a gender×mental disorder term, whose p value calculated using a Wald-χ² Test.

  • *Any mood disorder includes major depressive episode and dysthymia.

  • †Any anxiety disorder includes panic, specific phobia, social phobia, agoraphobia, generalised anxiety and post-traumatic stress disorders.

  • MHC, mental healthcare.